FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Glenwood Goss

Research Profile

Disorders

Procedures

Chemicals & Drugs

Concepts & Ideas

Co-author Network

Publications

TOP 3
Charles Butts; Yvon Cormier; Peter M Ellis; Martin Falk; Glenwood Goss; Andrew Maksymiuk; Ernie Marshall; Allan Price; Ravinder Sawhney; Denis Soulières; Frank Beier; Nevin Murray
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.
D J Jonker; L S Rosen; M B Sawyer; F de Braud; G Wilding; C J Sweeney; G C Jayson; G A McArthur; G Rustin; Glenwood Goss; J Kantor; L Velasquez; S Syed; O Mokliatchouk; D M Feltquate; G Kollia; D S A Nuyten; S Galbraith
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.
Charles Butts; R Nevin Murray; Colum J Smith; Peter M Ellis; Kevin Jasas; Andrew Maksymiuk; Glenwood Goss; Guy Ely; Frank Beier; Denis Soulières
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Glenwood Goss (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Charles Butts; Yvon Cormier; Peter M Ellis; Martin Falk; Glenwood Goss; Andrew Maksymiuk; Ernie Marshall; Allan Price; Ravinder Sawhney; Denis Soulières; Frank Beier; Nevin Murray
Updated survival analysis in patients with stage IIIB or IV non-small-cell lung cancer receiving BLP25 liposome vaccine (L-BLP25): phase IIB randomized, multicenter, open-label trial.
Journal of cancer research and clinical oncology 2011;137(9):1337-42.
2011: D J Jonker; L S Rosen; M B Sawyer; F de Braud; G Wilding; C J Sweeney; G C Jayson; G A McArthur; G Rustin; Glenwood Goss; J Kantor; L Velasquez; S Syed; O Mokliatchouk; D M Feltquate; G Kollia; D S A Nuyten; S Galbraith
A phase I study to determine the safety, pharmacokinetics and pharmacodynamics of a dual VEGFR and FGFR inhibitor, brivanib, in patients with advanced or metastatic solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(6):1413-9.
2010: Charles Butts; R Nevin Murray; Colum J Smith; Peter M Ellis; Kevin Jasas; Andrew Maksymiuk; Glenwood Goss; Guy Ely; Frank Beier; Denis Soulières
A multicenter open-label study to assess the safety of a new formulation of BLP25 liposome vaccine in patients with unresectable stage III non-small-cell lung cancer.
Clinical lung cancer 2010;11(6):391-5.
2010: Charles Butts; Keyue Ding; Lesley Seymour; Philip Twumasi-Ankrah; Barbara Graham; David R Gandara; David H Johnson; Kenneth A Kesler; Mark Green; mark vincent; Yvon Cormier; Glenwood Goss; Brian Findlay; Michael Johnston; Ming-Sound Tsao; Frances A Shepherd
Randomized phase III trial of vinorelbine plus cisplatin compared with observation in completely resected stage IB and II non-small-cell lung cancer: updated survival analysis of JBR-10.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):29-34.
2009: Heather A Wakelee; Billy W Loo; Kemp H Kernstine; Joe Bill Putnam; Martin J Edelman; Everett E Vokes; Joan H Schiller; Paul Baas; Nagahiro Saijo; Alex Adjei; Glenwood Goss; Hak Choy; David R Gandara
Cooperative group research efforts in thoracic malignancies 2009: a review from the 10th Annual International Lung Cancer Congress.
Clinical lung cancer 2009;10(6):395-404.
2009: Randeep Sangha; Primo Lara; Alex A Adjei; Paul Baas; Hak Choy; Laurie E Gaspar; Glenwood Goss; Nagahiro Saijo; Joan H Schiller; Everett E Vokes; David R Gandara
Cooperative group research endeavors in small-cell lung cancer: current and future directions.
Clinical lung cancer 2009;10(5):322-30.
2009: Natasha B Leighl; Scott A Laurie; Xueyu E Chen; Peter Ellis; Frances A Shepherd; Jennifer J Knox; Glenwood Goss; Ronald L Burkes; Gregory R Pond; Christopher Dick; Yun Yen; James A Zwiebel; Malcolm J Moore
A phase I/II study of GTI-2040 plus docetaxel as second-line treatment in advanced non-small cell lung cancer: a study of the PMH phase II consortium.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2009;4(9):1163-9.
2009: Glenwood Goss; David Ferry; Rafal Wierzbicki; Scott A Laurie; Joyce Thompson; Bonne Biesma; Fred R Hirsch; Marileila Varella-Garcia; Emma Duffield; Ozlem U Ataman; Marc Zarenda; Alison A Armour
Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(13):2253-60.
2009: Glenwood Goss; Frances A Shepherd; Scott A Laurie; Isabelle Gauthier; N Leighl; Eric Chen; Ronald Feld; Jean Powers; Lesley Seymour
A phase I and pharmacokinetic study of daily oral cediranib, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with cisplatin and gemcitabine in patients with advanced non-small cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group.
European journal of cancer (Oxford, England : 1990) 2009;45(5):782-8.
2009: Simon J Crabb; Demetris Patsios; Eric Sauerbrei; Peter M Ellis; Andrew Arnold; Glenwood Goss; Natasha B Leighl; Frances A Shepherd; Jean Powers; Lesley Seymour; Scott A Laurie
Tumor cavitation: impact on objective response evaluation in trials of angiogenesis inhibitors in non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(3):404-10.
2008: Scott A Laurie; Isabelle Gauthier; Andrew Arnold; Frances A Shepherd; Peter M Ellis; Eric Chen; Glenwood Goss; Jean Powers; Wendy Walsh; Dongsheng Tu; Jane Robertson; Thomas A Puchalski; Lesley Seymour
Phase I and pharmacokinetic study of daily oral AZD2171, an inhibitor of vascular endothelial growth factor tyrosine kinases, in combination with carboplatin and paclitaxel in patients with advanced non-small-cell lung cancer: the National Cancer Institute of Canada clinical trials group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(11):1871-8.
2008: Gregory R Pond; Lillian L Siu; Malcolm Moore; Amit Oza; Hal Hirte; Eric Winquist; Glenwood Goss; Gary Hudes; Carol A Townsley
Nomograms to predict serious adverse events in phase II clinical trials of molecularly targeted agents.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(8):1324-30.
2007: Andrew M Arnold; Lesley Seymour; Michael Smylie; Keyue Ding; Yee C Ung; Brian Findlay; Christopher W Lee; Marina Djurfeldt; Marlo Whitehead; Peter Ellis; Glenwood Goss; Adrien Chan; Jacinta Meharchand; Yasmin Alam; Richard Gregg; Charles Butts; Peter Langmuir; Frances A Shepherd
Phase II study of vandetanib or placebo in small-cell lung cancer patients after complete or partial response to induction chemotherapy with or without radiation therapy: National Cancer Institute of Canada Clinical Trials Group Study BR.20.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(27):4278-84.
2007: Raymond Ng; Baktiar Hasan; Nicole Mittmann; Marie Florescu; Frances A Shepherd; Keyue Ding; Charles Butts; Yvon Cormier; Gail Darling; Glenwood Goss; Richard Inculet; Lesley Seymour; Timothy Winton; William K Evans; Natasha B Leighl
Economic analysis of NCIC CTG JBR.10: a randomized trial of adjuvant vinorelbine plus cisplatin compared with observation in early stage non-small-cell lung cancer--a report of the Working Group on Economic Analysis, and the Lung Disease Site Group, National Cancer Institute of Canada Clinical Trials Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2256-61.
2007: Alejandro Lazo-Langner; Glenwood Goss; Johanna N Spaans; Marc A Rodger
The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials.
Journal of thrombosis and haemostasis : JTH 2007;5(4):729-37.
2006: Ignacio Duran; Jeremy Kortmansky; D Singh; Hal Hirte; W Kocha; Glenwood Goss; L Le; Amit Oza; Trudey Nicklee; James Ho; Diana Birle; Gregory R Pond; D Arboine; Janet E Dancey; S Aviel-Ronen; Ming Tsao; David W Hedley; Lillian L Siu
A phase II clinical and pharmacodynamic study of temsirolimus in advanced neuroendocrine carcinomas.
British journal of cancer 2006;95(9):1148-54.
2006: Glenwood Goss; Lillian L Siu; I Gauthier; Eric X Chen; Amit Oza; Rakesh Goel; Jean Maroun; J Powers; Wendy Walsh; Martha Maclean; D W Drolet; J Rusk; LK Seymour
A phase I, first in man study of OSI-7836 in patients with advanced refractory solid tumors: IND.147, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
Cancer chemotherapy and pharmacology 2006;58(5):703-10.
2006: Jean Maroun; K Belanger; Lesley Seymour; Sarah Matthews; J Roach; Jeanne Dionne; Denis Soulieres; D Stewart; Rakesh Goel; Danielle Charpentier; Glenwood Goss; Eva Tomiak; JC Yau; J Jimeno; G Chiritescu
Phase I study of Aplidine in a dailyx5 one-hour infusion every 3 weeks in patients with solid tumors refractory to standard therapy. A National Cancer Institute of Canada Clinical Trials Group study: NCIC CTG IND 115.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2006;17(9):1371-8.
2006: Jim Dimitroulakos; Ian A J Lorimer; Glenwood Goss
Strategies to enhance epidermal growth factor inhibition: targeting the mevalonate pathway.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 2):4426s-4431s.
2006: Thomas J Lynch; Alex A. Adjei; Paul A Bunn; Tim G Eisen; Jeffrey A Engelman; Glenwood Goss; Daniel A Haber; John V Heymach; Pasi A Janne; Bruce E Johnson; David H Johnson; Rogerio Lilenbaum; Matthew Meyerson; Alan B Sandler; Lecia V Sequist; Jeffrey Settleman; Kwok-Kin Wong; Carol S Hart
Summary statement: novel agents in the treatment of lung cancer: advances in epidermal growth factor receptor-targeted agents.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 2):4365s-4371s.
2006: Natasha B Leighl; Glenwood Goss; P G Lopez; Ronald L Burkes; Janet E Dancey; Y H Rahim; L C Rudinskas; J F Pouliot; A Rodgers; Gregory R Pond; Frances A Shepherd
Phase II study of pegylated liposomal doxorubicin HCl (Caelyx) in combination with cyclophosphamide and vincristine as second-line treatment of patients with small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2006;52(3):327-32.
2006: Carol A Townsley; Gregory R Pond; Amit Oza; Hal Hirte; Eric Winquist; Glenwood Goss; Pamela Degendorfer; Malcolm J Moore; Lillian L Siu
Evaluation of adverse events experienced by older patients participating in studies of molecularly targeted agents alone or in combination.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(7 Pt 1):2141-9.
2005: Charles Butts; Nevin Murray; Andrew Maksymiuk; Glenwood Goss; Ernie Marshall; Denis Soulières; Yvon Cormier; Peter Ellis; Allan Price; Ravinder Sawhney; Mary Davis; Janine Mansi; Colum Smith; Dimitrios Vergidis; Paul Ellis; Mary MacNeil; Martin Palmer
Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6674-81.
2005: Thomas J Lynch; Jeffrey A. Bogart; Walter Curran; Malcolm M DeCamp; David R Gandara; Glenwood Goss; Claudia I Henschke; James R Jett; Bruce E Johnson; Karen L Kelly; Thierry Le Chevalier; James L Mulshine; Giorgio V Scagliotti; Joan H Schiller; Alice Shaw; Nick Thatcher; Everett E Vokes; Douglas E Wood; Carol Hart
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4981s-4983s.
2005: Timothy Winton; Robert Livingston; David Johnson; James Rigas; Michael Johnston; Charles Butts; Yvon Cormier; Glenwood Goss; Richard Inculet; Eric Vallieres; Willard Fry; Drew Bethune; Joseph Ayoub; Keyue Ding; Lesley Seymour; Barbara Graham; Ming Tsao; David R Gandara; Kenneth Kesler; Todd L Demmy; Frances A Shepherd
Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer.
The New England journal of medicine 2005;352(25):2589-97.
2005: Angela J Mantha; Jennifer E L Hanson; Glenwood Goss; Alain E Lagarde; Ian A J Lorimer; Jim Dimitroulakos
Targeting the mevalonate pathway inhibits the function of the epidermal growth factor receptor.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(6):2398-407.
2005: Glenwood Goss; Hal Hirte; Wilson H Miller; Ian A J Lorimer; David Stewart; Gerald Batist; Doris A E Parolin; P Hanna; S Stafford; J Friedmann; Wendy Walsh; S Mathews; Lynn Douglas; LK Seymour
A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group.
Investigational new drugs 2005;23(2):147-55.
2004: John V Heymach; Jayesh Desai; Judith Manola; Darren W Davis; David J McConkey; David Harmon; David P Ryan; Glenwood Goss; Travis Quigley; Annick D Van den Abbeele; Stuart G Silverman; Susan Connors; Judah Folkman; Christopher D M Fletcher; George D Demetri
Phase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(17):5732-40.
2003: Angela J Mantha; Kathryn E McFee; Nima Niknejad; Glenwood Goss; Ian A J Lorimer; Jim Dimitroulakos
Epidermal growth factor receptor-targeted therapy potentiates lovastatin-induced apoptosis in head and neck squamous cell carcinoma cells.
Journal of cancer research and clinical oncology 2003;129(11):631-41.
2003: Manijeh Daneshmand; Doris A E Parolin; Hal Hirte; Pierre Major; Glenwood Goss; David Stewart; Gerald Batist; Wilson H Miller; Sarah Matthews; Lesley Seymour; Ian A J Lorimer
A pharmacodynamic study of the epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 in metastatic colorectal cancer patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(7):2457-64.
2001: M Knowling; George Browman; Lillian Siu; K Khoo; A Cooke; I Tannock; D Klaassen; C Cripps; Glenwood Goss; Sarah Matthews; R Clarke; Lesley Seymour
A National Cancer Institute of Canada clinical trials group phase II study of eniluracil (776C85) and oral 5-fluorouracil in patients with advanced squamous cell head and neck cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(7):919-22.
1999: C Lochrin; Glenwood Goss; David J Stewart; PW Cross; OO Agboola; Simone Dahrouge; Eva Tomiak; William K Evans
Concurrent chemotherapy with hyperfractionated accelerated thoracic irradiation in stage III non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1999;23(1):19-30.
1998: JC Yau; CJ Germond; Stefan Gluck; C Cripps; S Verma; B F Burns; TM Koski; D C Lister; Glenwood Goss
Mitoxantrone, prednimustine, and vincristine for elderly patients with aggressive non-Hodgkin's lymphoma.
American journal of hematology 1998;59(2):156-60.
1998: Glenwood Goss; L Paszat; TE Newman; William K Evans; George Browman
Use of preoperative chemotherapy with or without postoperative radiotherapy in technically resectable stage IIIA non-small-cell lung cancer. Provincial Lung Cancer Disease Site Group.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1998;2(1):32-9.
1997: William K Evans; Craig C Earle; David J Stewart; Simone Dahrouge; Eva Tomiak; Glenwood Goss; DM Logan; Rakesh Goel; Stan Gertler; H Dulude
Phase II study of a one hour paclitaxel infusion in combination with carboplatin for advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1997;18(1):83-94.
1997: Glenwood Goss; DM Logan; TE Newman; William K Evans
Use of vinorelbine in non-small-cell lung cancer. Provincial Lung Disease Site Group.
Cancer prevention & control : CPC = Prévention & contrôle en cancérologie : PCC 1997;1(1):28-38.
1996: David J Stewart; Eva Tomiak; Glenwood Goss; Stan Gertler; D Logan; SD Huan; JC Yau; H Dulude; William K Evans
Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 1996;15(1):115-23.
1996: Glenwood Goss; Simone Dahrouge; C A Lochrin
Recent advances in the treatment of non-small cell lung cancer.
Anti-cancer drugs 1996;7(4):363-85.
1995: William K Evans; A Radwi; Eva Tomiak; D M Logan; H Martins; David J Stewart; Glenwood Goss; Jean Maroun; Simone Dahrouge
Oral etoposide and carboplatin. Effective therapy for elderly patients with small cell lung cancer.
American journal of clinical oncology 1995;18(2):149-55.
1994: William K Evans; David J Stewart; Frances A Shepherd; D Logan; Glenwood Goss; Jean Maroun; R Wierzbicki; E Warner; Jean Latreille; Simone Dahrouge
VP-16, ifosfamide and cisplatin (VIP) for extensive small cell lung cancer.
European journal of cancer (Oxford, England : 1990) 1994;30A(3):299-303.
1993: Glenwood Goss; mark vincent; CJ Germond; S Corringham; J Rowen; H Dhaliwal; R Corringham
Combination chemotherapy with teniposide (VM26) and carboplatin in small cell lung cancer.
American journal of clinical oncology 1993;16(4):295-300.
1992: William K Evans; D Stewart; D Logan; Jean Maroun; Glenwood Goss; Frances A Shepherd; Jean Latreille; E Warner; Simone Dahrouge
A phase II study of ifosfamide in combination with etoposide and cisplatin in the treatment of extensive small cell lung cancer.
Seminars in oncology 1992;19(6 Suppl 12):51-6.
1992: Glenwood Goss; mark vincent; R Corringham; CJ Germond; C Sinoff; G Kane; J Rowen; S Corringham; H Dhaliwal
Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
Seminars in oncology 1992;19(2 Suppl 6):69-74.